We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
Cap. Flow
-$152M
Cap. Flow %
-0.64%
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$117M
2
ENTG icon
Entegris
ENTG
+$107M
3
TFX icon
Teleflex
TFX
+$26.6M
4
NKE icon
Nike
NKE
+$25.8M
5
SPGI icon
S&P Global
SPGI
+$20.9M

Sector Composition

Rank Sector Weight
1 Financials 43.69%
2 Technology 15.09%
3 Healthcare 11.64%
4 Consumer Discretionary 8.73%
5 Communication Services 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILI icon
101
Bilibili
BILI
$7.32B
$17.6M 0.07%
1,150,654
-275
-0% -$6.26K
ADP icon
102
Automatic Data Processing
ADP
$97.1B
$17.5M 0.07%
77,216
-850
-1% -$201K
MSEX icon
103
Middlesex Water
MSEX
$1.05B
$17.2M 0.07%
222,865
-3,400
-2% -$304K
CMC icon
104
Commercial Metals
CMC
$7.53B
$17.2M 0.07%
483,674
-8,200
-2% -$316K
AEE icon
105
Ameren
AEE
$31.3B
$17M 0.07%
211,083
-2,200
-1% -$201K
VMEO
106
DELISTED
Vimeo
VMEO
$16.4M 0.07%
4,107,052
-1,308,800
-24% -$7.74M
MIR icon
107
Mirion Technologies
MIR
$4.13B
$15.8M 0.07%
2,112,734
+280,125
+15% +$1.97M
CVS icon
108
CVS Health
CVS
$136B
$15.5M 0.07%
162,247
-2,310
-1% -$229K
NVS icon
109
Novartis
NVS
$297B
$15.3M 0.06%
201,100
-2,034
-1% -$169K
TEL icon
110
TE Connectivity
TEL
$57.6B
$15.2M 0.06%
137,933
-50
-0% -$6.22K
NICE icon
111
Nice
NICE
$5.09B
$14.9M 0.06%
86,163
+86,063
+86,063% +$18M
CBZ icon
112
CBIZ
CBZ
$2.16B
$14.9M 0.06%
347,455
-99,175
-22% -$4.34M
COP icon
113
ConocoPhillips
COP
$146B
$14.7M 0.06%
143,592
+7
+0% +$698
RPM icon
114
RPM International
RPM
$13.4B
$14.6M 0.06%
175,786
-2,974
-2% -$264K
MLM icon
115
Martin Marietta Materials
MLM
$32.8B
$14.5M 0.06%
44,992
-9
-0% -$3.05K
WFC.PRL icon
116
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$14.1M 0.06%
11,675
+413
+4% +$517K
LBRDK icon
117
Liberty Broadband Class C
LBRDK
$4.26B
$14M 0.06%
208,864
-15,221
-7% -$1.62M
BA icon
118
Boeing
BA
$165B
$13.5M 0.06%
111,845
+416
+0.4% +$63.8K
A icon
119
Agilent Technologies
A
$39.5B
$13.4M 0.06%
110,578
-391
-0.4% -$50.2K
SPY icon
120
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$13.2M 0.06%
36,999
+2,619
+8% +$1.04M
ENTA icon
121
Enanta Pharmaceuticals
ENTA
$377M
$12.6M 0.05%
243,718
+15,911
+7% +$930K
AXS icon
122
AXIS Capital
AXS
$8.45B
$12.3M 0.05%
250,485
-212
-0.1% -$11.2K
IDXX icon
123
Idexx Laboratories
IDXX
$42.5B
$12.2M 0.05%
37,426
JEF icon
124
Jefferies Financial Group
JEF
$12.8B
$12M 0.05%
424,698
-781
-0.2% -$23.6K
BKNG icon
125
Booking.com
BKNG
$134B
$11.8M 0.05%
178,775
-24,450
-12% -$1.84M

Similar funds

First Manhattan's Q3 2022 Portfolio in Review

As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.

By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
  • First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
  • First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
  • First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
  • First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
  • First Manhattan opened 84 new positions and closed 104 in Q3 2022.
  • First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.

Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.